Ms Yun Huang

Shanghai (China)

Follow

Contributor content

An open-label extension study of aficamten for Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy: 48-week results

Presentation

An open-label extension study of aficamten for Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy: 48-week results

ESC 365 is supported by

novartis

Explore sponsored resources